D. Guerrero Patiño

Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis

J. Buendía, Erika Fernanda Lindarte, D. Guerrero Patiño, 2022, BMC Pulmonary Medicine.

High-flow nasal cannula for acute exacerbation of chronic obstructive pulmonary disease: a Cost-utility analysis

J. Buendía, D. Guerrero Patiño, Jefferson Antonio Buendía, 2022, medRxiv.

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis

J. Buendía, Diana Guerrero Patiño, D. Guerrero Patiño, 2022, BMC Pulmonary Medicine.

Cost-effectiveness of procalcitonin for detection of serious bacterial infections in children presenting with fever without source

J. Buendía, Diana Guerrero Patiño, D. Guerrero Patiño, 2022, BMC Pediatrics.

Importance of respiratory syncytial virus as a predictor of hospital length of stay in bronchiolitis

J. Buendía, D. Guerrero Patiño, 2020, F1000Research.

Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis.

J. Buendía, Erika Fernanda Lindarte, D. Guerrero Patiño, 2023, Value in health regional issues.

Cost Utility of Intermittent Inhaled Corticosteroids in Preschoolers with Viral-Triggered Wheeze.

J. Buendía, Diana Guerrero Patiño, Juan Esteban Giraldo Ramírez, 2022, Pediatric allergy, immunology, and pulmonology.

Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma.

J. Buendía, Diana Guerrero Patiño, H. Talamoni, 2021, Pediatric pulmonology.